From Name:
From Email:
To Name:
To Email:

Optional Message:


Sigma Life Science gains rights to iPSC technology from iPS Academia Japan

from Genetic Engineering & Biotechnology News

Sigma Life Science obtained a worldwide license to Kyoto University's induced pluripotent stem cell patent portfolio in return for a license fee paid to iPS Academia Japan. The Sigma-Aldrich biological product and services business is already exploiting a zinc finger protein platform and stem cell technology portfolio. The company says the licensed technology will enable it to develop new tools for drug discovery and preclinical research, including iPSCs, iPSC-derived primary cells, assays, custom cell lines and ADME/Tox services. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063